LIV-GAMMA SN Inj.10%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LIV-GAMMA SN Inj.10%, covering 2022-10-05 to 2022-10-05. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP) [Phase 3]